Skip to main content
. 2022 May 8;30(8):6785–6793. doi: 10.1007/s00520-022-07117-z

Table 1.

Baseline characteristics of the study patients

Characteristics Endometrioid cancer
N = 328
Ovarian cancer
N = 90
Cervical cancer
N = 107
p value
Age at first consultation, years 57 (26–84)o,c 45.5 (30–75)e,c 43 (23–78)e,o  < 0.001
Age at surgery, years 50 (24–60)o,c 44 (26–56)e,c 40.5 (23–56)e,o  < 0.001
Time since surgery, months 31 (1–333) 25 (1–212) 20 (1–366) 0.343
Time since surgery, N (%)
   < 1 year 84 (25.6) 20 (22.2) 34 (31.8) 0.291
  1–5 years 132 (40.2) 46 (51.1) 44 (41.1)
   > 5 years 112 (34.1) 24 (26.7) 29 (27.1)
Body mass index, kg/m2 22.1 (12.6–38.1)o,c 20.5 (15.5–28.9)e 20.3 (13.0–30.0)e  < 0.001
Body mass index, N (%)
   < 18.5 kg/m2 35 (10.7) 17 (18.9) 20 (18.7)  < 0.001
  18.5–25 kg/m2 211 (64.3) 66 (73.3) 79 (73.8)
   > 25 kg/m2 82 (25.0)o,c 7 (7.8)e 8 (7.5)e
Menopausal status at surgery, N (%)
  Premenopausal 3 (0.9)c 2 (2.2)c 28 (26.2)e,o  < 0.001
  Postmenopausal 325 (99.1) 88 (97.8) 79 (73.8)
Additional treatment, N (%)
  Chemotherapy only 83 (25.3)o 56 (62.2)e,c 32 (29.9)o  < 0.001
  Radiation only 5 (1.5)c 0 (0.0) 7 (6.5)e
  Chemoradiation 0 (0.0)c 0 (0.0)c 7 (6.5)e,o
  None 240 (73.2)o,c 34 (37.8)e,c 61 (57.0)e,o

Data represent the median (range) unless otherwise indicated. p value based on Kruskal–Wallis test for sequential items followed by Mann–Whitney U test adjusted by Holm's method and Fisher’s exact test for nominal categories followed by the test for equal proportions adjusted by Holm’s method. Superscripts e, o, and c indicate significant difference compared with endometrial, ovarian, and cervical cancer, respectively